Press Releases

To read the full text of the following news releases, please click on the title:

Date Title
October 30, 2008

Dow Pharmaceutical Sciences to present scientific poster at AAPS evaluating the affect of flow rate, tissue thickness and receptor phase type on drug penetration when applied topically to dermatomed and dermis only skin.
September 4, 2008

Dow Pharmaceutical Sciences, Inc. Expands Clinical Labeling Capabilities in Petaluma, California
April 16, 2008 ''Dermatological Product Development'' Workshop to be Held May 29-30, 2008 in Hamburg, Germany
March 27, 2008 Dr. David Osborne Presents "Dermatological Product Development for Managers", April 24th-25th, 2008 at Missouri State University
September 4, 2007 Dow Pharmaceutical Sciences, Inc. Added To FIRST-EVER LIST OF THE 5,000 FASTEST-GROWING BUSINESSES in the U.S.
November 7, 2006 Medicis and Dow Pharmaceutical Sciences Announce FDA Approval of Ziana (Clindamycin Phosphate 1.2% and Tretinoin 0.025%) Gel
October 24, 2006 4.0 SkinMedica(R) Announces FDA Approval Of Desonate(TM) (Desonide) Gel 0.05% With Patented Hydrogel Technology For Treatment Of Atopic Dermatitis
April 25, 2006 New Bovine In Vitro Ocular Permeation Model at ARVO 2006 Annual Meeting
November 2, 2005 Dow Pharmaceutical Sciences Receives FDA Approval of NDA for Galderma’s Clobex® Spray for Moderate-to-Severe Plaque Psoriasis
July 6, 2005 Dow Pharmaceutical Sciences Announces FDA Approval of METROGEL® (metronidazole) Topical Gel 1% for Rosacea

 

Media Contact

Steve Smith : Dow Pharmaceutical Sciences : 707.793.2600 x672.